Skip to main content

Vaxxinity, Inc. (VAXX)

NASDAQ: VAXX · IEX Real-Time Price · USD
10.94 -1.50 (-12.06%)
Dec 1, 2021 4:00 PM EST - Market closed

Company Description

Vaxxinity is a purpose-driven biotechnology company committed to democratizing healthcare across the globe.

Our vision is to disrupt the existing treatment paradigm for chronic diseases. We believe our synthetic peptide vaccine platform has the potential to enable a new class of therapeutics that will improve the quality and convenience of care, reduce costs and increase access to treatments for a wide range of indications.

Our Vaxxine Platform is designed to harness the immune system to convert the body into its own “drug factory,” stimulating the production of antibodies with a therapeutic or protective effect.

Specifically, our technology uses synthetic peptides to mimic and optimally combine biological epitopes in order to selectively activate the immune system, producing antibodies against only the desired targets, including self-antigens, making possible the safe and effective treatment of chronic diseases by vaccines.

The modular and synthetic nature of our Vaxxine Platform generally provides significant speed and efficiency in candidate development and has generated multiple product candidates that we are designing to have safety and efficacy equal to or greater than the standard-of-care treatments for many chronic diseases, with more convenient administration and meaningfully lower costs.

Our current pipeline consists of five chronic disease product candidates from early to late-stage development across multiple therapeutic areas including Alzheimer’s Disease, Parkinson’s Disease, migraine and hypercholesterolemia.

We also will opportunistically pursue infectious disease treatments.

Vaxxinity, Inc.
CountryUnited States
Founded2019
IPO DateNov 11, 2021
IndustryBiotechnology
SectorHealthcare
Employees75
CEOMei Mei Hu

Contact Details

Address:
1717 Main St, Ste 3388
Dallas, TX 75201
United States
Phone(254) 244-5739
Websitevaxxinity.com

Stock Details

Ticker SymbolVAXX
ExchangeNASDAQ
Fiscal YearJanuary - December
Reporting CurrencyUS Dollars
IPO Price$13.00
CIK Code1851657

Key Executives

NamePosition
Mei Mei HuCo-Founder, President, Chief Executive Officer and Director
Farshad GuirakhooChief Scientific Officer
Ulo PalmChief Medical Officer
Martin DoranTreasurer and Principal Accounting Officer
René Paula MolinaGeneral Counsel and Secretary
Louis ReeseCo-Founder and Executive Chairman of the Board
Gregory R. BlattDirector
James ChuiDirector

Latest SEC Filings

DateTypeTitle
Nov 18, 20214Statement of changes in beneficial ownership of securities
Nov 18, 20214Statement of changes in beneficial ownership of securities
Nov 17, 20218-KCurrent report
Nov 15, 20214Statement of changes in beneficial ownership of securities
Nov 15, 20214Statement of changes in beneficial ownership of securities
Nov 15, 20214Statement of changes in beneficial ownership of securities
Nov 15, 20214Statement of changes in beneficial ownership of securities
Nov 15, 20214Statement of changes in beneficial ownership of securities
Nov 15, 20214Statement of changes in beneficial ownership of securities
Nov 15, 20214Statement of changes in beneficial ownership of securities
View All SEC Filings